Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity

Oncology Research

Volumn 12, Issue 9-10, 2000, Pages 361-370

  Coronnello, Marcella ^a   Marcon, Giordana ^b   Carotti, Stefania ^a   Caciagli, Barbara ^a   Mini, Enrico ^a   Mazzei, Teresita ^a   Orioli, Pierluigi ^a   Messori, Luigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CIRCSMB   (Italy)

Author keywords

COMET assay; Cytotoxicity; Flow cytometry; Gold(III) complexes

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA; GOLD;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL LINE; CHEMICAL MODEL; COMET ASSAY; DNA DAMAGE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IC 50; LEUKEMIA; TIME;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE; CISPLATIN; COMET ASSAY; DNA; DNA DAMAGE; FLOW CYTOMETRY; GOLD; HUMANS; INHIBITORY CONCENTRATION 50; LEUKEMIA; MODELS, CHEMICAL; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034578457     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504001108747828     Document Type: Article

References (27)

1. Sadler, P. J. The biological chemistry of gold: A metallo-drug and heavy-atom label with variable valency. Struct. Bond. 29:171-210; 1976.
2. Ni Dhubhghaill, O. M.; Sadler, P. J. Gold complexes in cancer chemotherapy. In: Keppler, B. K., ed. Metal complexes in cancer chemoterapy. Weinheim: VCH; 1993:221-248.
3. Sadler, P. J.; Sue, R. E. The chemistry of gold drugs. Metal Based Drugs 1:107-144; 1994.
4. Buckley, R. G.; Elsome, A. M.; Fricker, S. P.; Henderson, G. R.; Theobald, B. R. C.; Parish, R. V.; Howe, B. P.; Kelland, L. R. Antitumor properties of some 2-[(dimethylamino)methyl]phenyl-gold(III) complexes. J. Med. Chem. 39:5208-5214; 1996.
5. Calamai, P.; Carotti, S.; Guerri, A.; Mazzei, T.; Messori, L.; Mini, E.; Orioli, P.; Speroni, G. P. Cytotoxic effects of gold(III)complexes on established human tumor cell lines sensitive and resistant to cisplatin. Anticancer Drug Design 13:67-80; 1998.
6. Cossu, F.; Matovic, Z.; Radanovic, D.; Ponticelli, G. Cytotoxic activity of some gold(III) complexes. Il Farmaco 49(4):301-302; 1994.
7. Mirabelli, C. K.; Johnson, R. K.; Sung, C. M.; Faucette, L. F.; Muirhead, K.; Crooke, S. T. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Cancer Res. 45(1):32-39; 1985.
8. Crooke, S. T.; Mirabelli, C. K. Molecular mechanisms of action of auranofin and other gold complexes as related to their biological activities. Am. J. Med. 75(6A):109-113; 1983.
9. Parish, R. V.; Howe, B. P.; Wright, J. P.; Mack, J.; Pritchard, R. G.; Buckley, R. G.; Elsome, A. M.; Fricker, S. P. Chemical and biological studies of dichloro(2-((dimethylamino)methyl)phenyl)gold(III). Inorg. Chem. 35:1659-1666; 1996.
10. 2(esal)]. Inorg. Chim. Acta 285:309-312; 1999.
11. Carotti, S.; Guerri, A.; Mazzei, T.; Messori, L.; Mini, E.; Orioli, P. Gold(III) compounds as potential antitumor agents: Cytotoxicity and DNA binding properties of some selected polyamine-gold(III) complexes. Inorg. Chim. Acta 281:90-94; 1998
12. Messori, L.; Abbate, F.; Marcon, G.; Orioli, P.; Fontani, M.; Mini, E.; Mazzei, T.; Carotti, S.; O'Connell, T.; Zanello, P. Gold(III) complexes as potential antitumor agents: Solution chemistry and cytotoxic properties of some selected gold(III) compounds. J. Med. Chem. 43(19):3541-2548; 2000.
13. Block, B. P.; Bailar, J. C. The reaction of gold(III) with some bidentate coordinating groups. J. Am. Chem. Soc. 73:4722-4725; 1951.
14. Nardin, G.; Randaccio, L.; Annibale, G.; Natile, G.; Pitteri, B. Comparison of structure and reactivity of bis(2-aminoethyl)amine-and bis(2-aminoethyl)amido-chlorogold(III) complexes. J. Chem. Soc. Dalton Trans. 220-223; 1979.
15. 2, determined by single-crystal X-ray diffraction, Raman and EXAFS spectroscopies: An EXAFS caveat. Inorg. Chem. 25:223-227; 1986.
16. 2: Exchange phenomena observed by H and C NMR spectroscopy. Metal Based Drugs 6(4-5):261-269; 1999.
17. Tice, R. R. The single cell gel/COMET assay: A microgel electrophoretic technique for the detection of DNA damage and repair in individual cells. In: Phillips, D. H.; Venit, S., eds. Environmetal mutagenesis. Oxford, UK: IOS Scientific Publishers; 1995:315-339.
18. 2 as a DNA fragmenting agent in the alkaline elution interstrand crosslinking and DNA-protein crosslinking assays. Anal. Biochem. 168(1):88-93; 1988.
19. Olive, P. L.; Vikse, C. M.; Banath, J. P. Use of the COMET assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice. Cancer Res. 56:4460-4463; 1996.
20. Hartley, J. M.; Spanswick, V. J.; Gander, M.; Giacomini, G.; Whelan, J.; Souhami, R. L.; Hartley, J. A. Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (COMET) assay. Clin. Cancer Res. 5:507-512; 1999.
21. Lanzi, C.; Perego, P.; Supino, R.; Romanelli, S.; Pensa, T.; Carenini, N.; Viano, I.; Colangelo, D.; Leone, R.; Apostoli, P.; Cassinelli, G.; Gambetta, R. A.; Zunino, F. Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance. Biochem. Pharmacol. 55(8): 1247-1254; 1998.
22. Vaisman, A.; Varchenko, M.; Said, I.; Chaney, S. G. Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity. Cytometry 27(1):54-64; 1997.
23. + current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J. Physiol. 489(2): 455-471; 1995.
24. Fairbairn, D. W.; Olive, P. L.; O'Neill, K. L. The COMET assay: A comprehensive review. Mutat. Res. 339:37-59; 1995.
25. Sekiguchi, M.; Suzuki, M.; Tamada, T.; Shinomiya, N.; Tsuru, S.; Murata, M. Effects of cisplatin on cell cycle kinetics, morphological change, and cleavage pattern of DNA in two human ovarian carcinoma cell lines. Oncology 53:19-26; 1996.
26. Demarcq, C.; Bastian, G.; Remvikos, Y. BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells. Cytometry 13:416-422; 1992.
27. Sorenson, C. M.; Eastman, A. Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: Role of G2 arrest and DNA double-strand breaks. Cancer Res. 48(16):4484-4488; 1988.